MOTS - Motus GI Holdings Inc Stock Price, Fair Value and News

0.11USD+0.02 (+22.22%)Delayed

Market Summary

USD0.11+0.02

Delayed

22.22%

MOTS Stock Price

View Fullscreen

MOTS RSI Chart

MOTS Valuation

Market Cap

634.6K

Price/Earnings (Trailing)

-0.06

Price/Sales (Trailing)

1.94

EV/EBITDA

0.2

Price/Free Cashflow

-0.08

MOTS Price/Sales (Trailing)

MOTS Profitability

Operating Margin

74.31%

EBT Margin

-5888.99%

Return on Equity

-345%

Return on Assets

-149.75%

Free Cashflow Yield

-1.3K%

MOTS Fundamentals

MOTS Revenue

Revenue (TTM)

327.0K

Rev. Growth (Yr)

14.29%

MOTS Earnings

Earnings (TTM)

-10.6M

Earnings Growth (Yr)

52.12%

Earnings Growth (Qtr)

25.13%

Breaking Down MOTS Revenue

Last 7 days

57.1%

Last 30 days

37.5%

Last 90 days

-82.8%

Trailing 12 Months

-99.1%

How does MOTS drawdown profile look like?

MOTS Financial Health

Current Ratio

1.74

Debt/Equity

0.22

Debt/Cashflow

-12.55

MOTS Investor Care

Shares Dilution (1Y)

1710.74%

Diluted EPS (TTM)

-4.61

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	327.0K	0	0	0
2023	628.0K	556.0K	364.0K	319.0K
2022	360.0K	445.0K	582.0K	592.0K
2021	121.0K	220.0K	328.0K	391.0K
2020	300.0K	297.0K	327.0K	98.0K
2019	155.3K	194.5K	233.8K	273.0K
2018	0	0	0	116.0K

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Motus GI Holdings Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Feb 10, 2022	taylor andrew lawrence	acquired	-	-	95,000	chief financial officer
Feb 10, 2022	pomeranz mark	acquired	-	-	95,000	president and coo
Feb 10, 2022	moran timothy p.	acquired	-	-	175,000	chief executive officer
Jan 05, 2022	hochman david p	acquired	-	-	127,083	-
Jan 05, 2022	pruden gary j	acquired	-	-	106,563	-
Jan 05, 2022	sherman darren	acquired	-	-	90,521	-
Jan 05, 2022	nelson sonja	acquired	-	-	82,500	-
Jan 05, 2022	korangy shervin j	acquired	-	-	82,500	-
Nov 19, 2021	taylor andrew lawrence	bought	1,021	0.5106	2,000	chief financial officer
Nov 19, 2021	moran timothy p.	bought	5,214	0.5214	10,000	chief executive officer

Which funds bought or sold MOTS recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 15, 2024	CITADEL ADVISORS LLC	new	-	7,445	7,445	-%
May 15, 2024	TWO SIGMA SECURITIES, LLC	new	-	9,024	9,024	-%
May 15, 2024	Tower Research Capital LLC (TRC)	added	170	-591	8,184	-%
May 15, 2024	ARMISTICE CAPITAL, LLC	added	105	-44,609	107,116	-%
May 15, 2024	MORGAN STANLEY	unchanged	-	-36.00	19.00	-%
May 13, 2024	HRT FINANCIAL LP	new	-	16,000	16,000	-%
May 13, 2024	UBS Group AG	new	-	7,120	7,120	-%
May 10, 2024	BlackRock Inc.	reduced	-11.68	-122	53.00	-%
May 10, 2024	OSAIC HOLDINGS, INC.	reduced	-84.12	-2,292	132	-%
May 10, 2024	WELLS FARGO & COMPANY/MN	added	114	-3.00	6.00	-%

Are Funds Buying or Selling MOTS?

Are funds buying MOTS calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own MOTS

No. of Funds

Unveiling Motus GI Holdings Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	armistice capital, llc	9.99%	152,450	SC 13G
Sep 22, 2023	orchestra biomed holdings, inc.	10.1%	804,096	SC 13G
Dec 29, 2021	feinberg larry n	0.22%	105,885	SC 13G/A
Feb 16, 2021	feinberg larry n	9.46%	3,806,666	SC 13G/A
Feb 16, 2021	armistice capital, llc	4.99%	1,675,086	SC 13G/A
Jan 27, 2021	perceptive advisors llc	8.3%	2,660,542	SC 13G/A
Sep 08, 2020	armistice capital, llc	9.6%	3,090,470	SC 13G
Feb 26, 2020	orchestra motus co-investment partners, llc	0.0%	0	SC 13D/A
Feb 26, 2020	orchestra biomed, inc.	7.1%	2,051,498	SC 13D/A
Feb 14, 2020	feinberg larry n	13.2%	3,806,666	SC 13G/A

Recent SEC filings of Motus GI Holdings Inc

View All Filings

Date Filed	Form Type	Document
May 14, 2024	10-Q	Quarterly Report
May 14, 2024	8-K	Current Report
Apr 25, 2024	25-NSE	25-NSE
Apr 11, 2024	8-K	Current Report
Apr 02, 2024	EFFECT	EFFECT
Apr 02, 2024	424B3	Prospectus Filed
Mar 29, 2024	CORRESP	CORRESP
Mar 28, 2024	UPLOAD	UPLOAD
Mar 22, 2024	S-3	S-3
Mar 18, 2024	8-K	Current Report

Peers (Alternatives to Motus GI Holdings Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	181.0B	40.3B	-1.75%	-4.07%	32.18	4.49	-2.84%	-3.08%
BDX	68.3B	19.7B	1.78%	-6.05%	51.24	3.46	4.82%	-17.56%
ALGN	20.4B	3.9B	-9.57%	-7.50%	44.2	5.22	5.72%	46.72%
BAX	18.0B	14.9B	-10.73%	-18.01%	6.79	1.21	2.98%	207.68%
MID-CAP
ATR	9.8B	3.5B	6.68%	24.08%	31.27	2.76	6.16%	35.06%
HSIC	9.6B	12.5B	6.31%	-2.51%	24.63	0.77	-0.61%	-18.83%
BIO	8.4B	2.6B	1.13%	-22.65%	-26.02	3.22	-6.25%	-68.62%
XRAY	5.9B	3.9B	-6.79%	-30.12%	-62.84	1.49	0.23%	91.03%
AXNX	3.4B	387.1M	0.52%	31.17%	-216.3	8.9	30.82%	65.57%
PDCO	2.3B	6.6B	0.19%	-5.50%	11.93	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	5.94%	-10.00%	-1.91	0.41	7.94%	-1661.78%
ANIK	376.6M	169.3M	-1.13%	-2.23%	-4.9	2.23	7.49%	-244.90%
ANGO	241.9M	324.0M	-4.58%	-37.15%	-1.26	0.75	-3.19%	-337.41%
APYX	56.1M	50.5M	22.73%	-73.49%	-2.46	1.11	14.25%	-10.06%
AEMD	1.0M	3.7M	-71.83%	-87.10%	-0.09	0.28	5.77%	8.23%

Motus GI Holdings Inc News

Latest updates

Motus GI Holdings Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	0%	64,000	64,000	86,000	113,000	56,000	109,000	278,000	185,000	20,000	99,000	141,000	100,000	51,000	36,000	33,000	1,000	28,000	265,000	3,000	4,000	34,500
Cost Of Revenue	-36.8%	12,000	19,000	22,000	31,000	9,000	32,000	83,000	68,000	15,000	46,000	65,000	42,000	28,000	23,000	32,000	10,000	30,000	71,000	62,000	2,000	1,000
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,000	-9,000	-2,000	28,000	-59,000	2,000	-
Costs and Expenses	-17.6%	2,090,000	2,536,000	2,480,000	2,795,000	4,415,000	4,136,000	4,983,000	4,778,000	4,546,000	4,654,000	4,478,000	4,690,000	4,493,000	-	3,856,000	4,221,000	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-5,000	-	4,493,000	4,385,000	3,824,000	4,211,000	6,740,000	6,175,000	5,361,000	5,649,000	6,358,000
S&GA Expenses	-38.1%	151,000	244,000	188,000	337,000	842,000	871,000	1,349,000	1,222,000	983,000	881,000	725,000	795,000	676,000	53,500	509,000	582,000	2,912,000	3,490,000	2,028,000	-	2,797,000
R&D Expenses	-18.9%	455,000	561,000	693,000	759,000	1,454,000	1,350,000	1,573,000	1,413,000	1,275,000	1,301,000	1,187,000	1,508,000	1,345,000	1,196,000	1,160,000	1,264,000	1,935,000	2,307,000	2,173,000	2,129,000	2,404,000
EBITDA Margin	1.4%	-55.53	-56.33	-49.17	-32.06	-28.30	-30.02	-30.55	-40.08	-50.05	-46.49	-55.87	-83.62	-151	-	-	-	-	-	-	-	-
Interest Expenses	-44.5%	81,000	146,000	214,000	230,000	246,000	198,000	268,000	267,000	244,000	197,000	221,000	112,000	110,000	112,000	112,000	112,000	97,000	-	-	-	-
Income Taxes	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings Before Taxes	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-4,398,000	-3,938,000	-4,410,000	-6,511,000	-5,937,000	-5,195,000	-5,681,000	-6,273,000
EBT Margin	2.4%	-58.89	-60.37	-52.90	-34.63	-30.66	-32.53	-33.09	-43.27	-53.49	-49.25	-58.71	-87.53	-159	-	-	-	-	-	-	-	-
Net Income	25.1%	-2,100,000	-2,805,000	-2,679,000	-2,997,000	-4,386,000	-3,682,000	-4,964,000	-5,140,000	-4,811,000	-4,818,000	-4,824,000	-4,742,000	-4,649,000	-4,398,000	-3,938,000	-4,410,000	-6,511,000	-5,937,000	-5,195,000	-5,681,000	-6,273,000
Net Income Margin	19.8%	-32.36	-40.34	-37.76	-28.83	-28.94	-31.41	-33.91	-44.03	-53.32	-48.68	-56.75	-80.58	-143	-	-	-	-	-	-	-	-
Free Cashflow	-7.8%	-2,000,000	-1,856,000	-1,981,000	-2,622,000	-4,839,000	-4,047,000	-3,784,000	-4,613,000	-5,247,000	-3,962,000	-3,066,000	-3,183,000	-4,681,000	-	-	-	-	-	-	-	-

Balance Sheet

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Balance Sheet																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-2.2%	7,066	7,223	8,491	11,741	12,231	17,647	17,366	20,082	24,425	26,089	27,078	30,193	31,869	24,064	27,735	21,438	25,996	32,257	29,766	13,802	18,321
Current Assets	-0.1%	5,750	5,757	6,742	9,810	10,257	15,370	15,487	18,193	22,403	23,961	24,878	28,017	29,814	22,107	25,912	19,480	23,870	30,167	27,682	11,961	16,476
Cash Equivalents	-2.0%	4,900	5,000	5,700	8,521	8,648	14,042	13,294	15,757	20,338	22,563	23,652	26,379	27,749	20,819	23,687	17,125	21,457	20,528	15,717	7,854	10,248
Inventory	-3.4%	479	496	-	-	-	999	1,014	1,038	700	496	515	706	770	805	1,295	1,325	1,232	1,014	771	93.00	115
Net PPE	-9.6%	897	992	1,101	1,209	1,237	1,325	1,395	1,329	1,366	1,428	1,438	1,451	1,312	1,178	994	1,062	1,140	1,056	1,015	920	842
Liabilities	-11.8%	3,999	4,536	10,969	12,704	13,316	14,670	16,604	16,110	15,818	16,432	13,298	12,602	12,444	12,774	12,736	12,549	13,375	13,929	6,180	5,710	5,238
Current Liabilities	1.2%	3,309	3,270	4,529	4,451	4,378	4,799	5,467	4,253	3,379	3,332	2,646	10,401	10,243	10,610	10,515	10,268	11,104	11,344	3,547	3,053	2,591
Long Term Debt	-46.0%	669	1,239	2,470	3,198	3,904	4,589	5,251	5,892	6,515	7,121	4,608	-	-	7,979	7,977	7,975	7,773	7,754	-	-	-
LT Debt, Current	58.0%	1,632	1,033	2,781	2,694	2,611	2,532	2,453	1,757	1,083	431	-	7,983	7,981	7,979	-	-	-	-	-	-	-
LT Debt, Non Current	-100.0%	-	1,239	2,470	3,198	3,904	4,589	5,251	5,892	6,515	7,121	-	-	-	-	-	-	-	-	-	-	-
Shareholder's Equity	14.1%	3,067	2,687	-	-	-1,085	2,977	762	3,972	8,606	9,657	13,780	17,591	19,425	11,290	14,999	8,889	12,621	18,328	23,586	8,092	13,083
Retained Earnings	-1.4%	-156,300	-154,218	-151,400	-148,734	-145,700	-141,351	-137,669	-132,705	-127,565	-122,754	-117,936	-113,112	-108,370	-103,721	-99,323	-95,385	-90,975	-84,464	-78,527	-73,332	-67,651
Additional Paid-In Capital	1.6%	159,397	156,905	148,935	147,770	144,652	144,328	138,431	136,677	136,166	132,411	131,711	130,698	127,790	115,008	114,319	104,271	103,593	102,789	102,110	81,422	80,732
Shares Outstanding	236.8%	5,211	1,547	530	354	319	310	202	184	184	161	161	161	156	-	-	-	-	-	-	-	-
Float	-	-	-	-	3,100	-	-	-	14,600	-	-	-	47,000	-	-	-	34,316	-	-	-	51,602	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-7.8%	-2,000	-1,856	-1,965	-2,573	-4,800	-4,038	-3,618	-4,565	-5,246	-3,917	-2,910	-3,053	-4,542	-2,980	-2,666	-4,140	-7,207	-5,520	-4,633	-4,176	-5,586
Share Based Compensation	-33.6%	71.00	107	93.00	49.00	222	386	441	461	521	695	848	1,010	919	663	785	653	804	675	730	859	941
Cashflow From Investing	-	-	-	-16.00	-49.00	-39.00	-9.00	-166	-48.00	-1.00	-45.00	-156	-130	-139	147	-10.00	-192	8,170	2,347	-7,741	1,845	-2,074
Cashflow From Financing	84.3%	2,009	1,090	-816	2,493	-553	4,795	1,321	32.00	3,022	2,873	339	1,813	11,611	-35.00	9,238	-	-34.00	7,984	20,237	-63.00	-142

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

MOTS Income Statement

2024-03-31

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenue	$ 64	$ 56
Operating expenses:
Cost of revenue - sales	12	9
Cost of revenue - impairment of inventory		165
Research and development	455	1,454
Sales and marketing	151	842
General and administrative	1,472	1,945
Total costs and expenses	2,090	4,415
Loss from operations	(2,026)	(4,359)
Gain on change in estimated fair value of contingent royalty obligation		220
Finance expense, net	(80)	(239)
Foreign currency loss	(7)	(8)
Net loss	(2,113)	(4,386)
Deemed dividends from warrant issuance	(5,508)
Net loss attributable to common shareholders	$ (7,621)	$ (4,386)
Basic and diluted loss per common share:
Net loss - Basic	$ (0.25)	$ (13.81)
Net loss - Diluted	(0.25)	(13.81)
Basic loss per common share	(0.88)	(13.81)
Diluted loss per common share	$ (0.88)	$ (13.81)
Weighted average number of common shares outstanding, basic	8,613,204	317,547
Weighted average number of common shares outstanding, diluted	8,613,204	317,547

MOTS Balance Sheet

2024-03-31

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 4,944	$ 4,958
Accounts receivable	81	76
Inventory, current	228	245
Prepaid expenses and other current assets	497	478
Total current assets	5,750	5,757
Fixed assets, net	897	992
Inventory, non-current	251	251
Right-of-use assets	155	210
Other non-current assets	13	13
Total assets	7,066	7,223
Current liabilities:
Accounts payable and accrued expenses	1,495	1,842
Operating lease liabilities - current	116	169
Other current liabilities	66	226
Current portion of long-term debt, net of unamortized debt discount of $91 and $108, respectively	1,632	1,033
Total current liabilities	3,309	3,270
Long-term debt, net of unamortized debt discount of $5 and $16, respectively	669	1,239
Operating lease liabilities - non-current	21	27
Total liabilities	3,999	4,536
Commitments and contingent liabilities (Note 9)
Shareholders’ equity
Common stock $0.0001 par value; 115,000,000 shares authorized; 5,210,876 and 1,547,042 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	1
Additional paid-in capital	159,397	156,905
Accumulated deficit	(156,331)	(154,218)
Total shareholders’ equity	3,067	2,687
Total liabilities and shareholders’ equity	$ 7,066	$ 7,223

About Motus GI Holdings Inc

Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. Motus GI Holdings, Inc. was founded in 2008 and is based in Fort Lauderdale, Florida.

CEO	Mr. Mark Pomeranz
WEBSITE	motusgi.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	43

Motus GI Holdings Inc Frequently Asked Questions

What is the ticker symbol for Motus GI Holdings Inc? What does MOTS stand for in stocks?

MOTS is the stock ticker symbol of Motus GI Holdings Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Motus GI Holdings Inc (MOTS)?

As of Fri May 17 2024, market cap of Motus GI Holdings Inc is 634.58 Thousand. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of MOTS stock?

You can check MOTS's fair value in chart for subscribers.

What is the fair value of MOTS stock?

You can check MOTS's fair value in chart for subscribers. The fair value of Motus GI Holdings Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Motus GI Holdings Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for MOTS so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Motus GI Holdings Inc a good stock to buy?

The fair value guage provides a quick view whether MOTS is over valued or under valued. Whether Motus GI Holdings Inc is cheap or expensive depends on the assumptions which impact Motus GI Holdings Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MOTS.

What is Motus GI Holdings Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, MOTS's PE ratio (Price to Earnings) is -0.06 and Price to Sales (PS) ratio is 1.94. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MOTS PE ratio will change depending on the future growth rate expectations of investors.